Inventor

Hun-Taek Kim

Inventor
Seoul, KR

Overview

20→
Patents
1995–2020
Patent span
Chemistry
Primary field (CPC C)

Patents· 20 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations22%
A61KPreparations for medical, dental or toiletry purposes19%
C07KPeptides12%
C12NMicroorganisms or enzymes12%
C07DHeterocyclic compounds10%
C12YEnzymes7%
C04BLime, magnesia5%
C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture5%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium2%
C08BPolysaccharides2%
PatentTitleYear
10,696,960Fusion protein having factor VII activity202010,155,7632-pyridyl substituted imidazoles as ALK5 and/or ALK4 inhibitors201810,058,607Polyvalent pneumococcal polysaccharide-protein conjugate composition201810,034,949Polyvalent pneumococcal polysaccharide-protein conjugate composition20189,987,339Pharmaceutical composition with improved stability containing factor VII fusion protein20189,981,029Multivalent pneumococcal polysaccharide-protein conjugate composition20189,926,361'Process for producing and purifying factor VIII and its derivatives'20189,644,197'Fusion protein having factor VII activity'20179,636,392'Production method for capsular polysaccharide having pneumococcal serotype'20179,622,986'Percutaneous absorption preparation containing donepezil, and method for preparing same'20179,617,328'Fusion protein having factor IX activity'20179,481,684'Gonadotropin releasing hormone receptor antagonists, method for the preparation thereof and pharmaceutical composition comprising the same'20169,447,383'MDCK-derived cell lines adapted to serum-free culture and suspension culture and method for preparing vaccine virus using the cells'20169,441,030'Process for producing and purifying factor VIII and its derivatives'20168,420,685'2-pyridyl substituted imidazoles as ALK5 and/or ALK4 inhibitors'20138,410,146'2-pyridyl substituted imidazoles as ALK5 and/or ALK4 inhibitors'20137,407,958'2-pyridyl substituted imidazoles as ALK5 and/or ALK4 inhibitors'20087,041,635'Factor VIII polypeptide'20065,889,013'Pyrimidine acyclonucleoside derivatives'19995,395,947'Platinum(II) complex and processes for preparing the same'1995

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1995–2020Based in Seoul, KR· patent location history
2008–2018Patents assigned to SK CHEMICALS CO LTD (14)· patent assignee history
2013–2017Patents assigned to KIM HUN-TAEK (5)· patent assignee history
2013–2017Patents assigned to LEE BONG-YONG (3)· patent assignee history
2016Based in Gyeonggi-do, KR· patent location history
2017–2018Patents assigned to SK CHEMICAL CO LTD (4)· patent assignee history
2017–2018Based in Suwon-si, KR· patent location history
2018–2020Patents assigned to TIUMBIO CO LTD (3)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
SK CHEMICALS CO LTD142008–2018
KIM HUN-TAEKself52013–2017
SK CHEMICAL CO LTD42017–2018
LEE BONG-YONG32013–2017
TIUMBIO CO LTD32018–2020
Locations
LocationPatentsSpan
Seoul, KR151995–2020
Suwon-si, KR42017–2018
Gyeonggi-do, KR12016